封面
市场调查报告书
商品编码
1974990

全球荐骨神经刺激器市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Sacral Nerve Stimulation Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

荐椎神经刺激市场预计将从 2025 年的 26.6 亿美元成长到 2034 年的 72.9 亿美元,2026 年至 2034 年的复合年增长率为 11.84%。

由于尿失禁和粪便失禁病例的不断增加,全球荐椎神经刺激市场正经历显着成长。荐椎神经刺激疗法为对传统治疗方法无效的患者提供了一种微创且有效的治疗选择。人们对骨盆底健康意识的提高和诊断能力的进步正在推动对这种先进治疗方法的需求不断增长。

植入式医疗器材的技术进步和电池续航力的提升是成长要素。各公司正致力于研发体积更小、可充电且相容核磁共振成像(MRI)的设备,以提升患者的便利性。已开发国家不断增长的医疗费用支出和优惠的报销政策进一步加速了此类设备的普及。此外,人口老化也带来了对膀胱和肠道疾病长期管理解决方案的持续需求。

荐椎神经刺激市场前景依然乐观,拓展治疗适应症的研究仍在持续。随着医疗基础设施的完善,新兴市场可望迎来新的成长机会。随着患者偏好转向微创和可持续的治疗方法,预计该市场将在预测期内稳步成长。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球荐骨神经刺激器市场:依产品划分

  • 市场分析、洞察与预测
  • 嵌入式社群网路服务设备
  • 外部社交网路服务设备

第五章 全球荐骨神经刺激器市场:依应用划分

  • 市场分析、洞察与预测
  • 尿失禁和粪便失禁
  • 慢性肛门裂伤
  • 尿失禁
  • 其他的

第六章 全球荐骨神经刺激器市场:按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第八章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic
    • Axonics Inc
    • Boston Scientific Corporation
    • Nervo Corp
    • Stimwave Technologies Inc
    • St. Jude Medical
    • Congentix Medical
    • Nevro Corp
    • Laborie Medical Technologies
    • BlueWind Medical
简介目录
Product Code: VMR112111259

The Sacral Nerve Stimulation Market size is expected to reach USD 7.29 Billion in 2034 from USD 2.66 Billion (2025) growing at a CAGR of 11.84% during 2026-2034.

The Global Sacral Nerve Stimulation Market is experiencing notable growth due to increasing cases of urinary incontinence and fecal incontinence. Sacral nerve stimulation therapy offers a minimally invasive and effective treatment option for patients who do not respond to conventional therapies. Rising awareness about pelvic health conditions and improved diagnostic capabilities are contributing to growing demand for this advanced therapy.

Technological advancements in implantable devices and battery life improvements are major growth drivers. Companies are focusing on developing smaller, rechargeable, and MRI-compatible devices to enhance patient convenience. Increasing healthcare spending and favorable reimbursement policies in developed countries are further accelerating adoption. Additionally, the aging population is creating consistent demand for long-term management solutions for bladder and bowel disorders.

Future prospects for the sacral nerve stimulation market remain positive, with ongoing research aimed at expanding its therapeutic applications. Emerging markets are expected to offer new growth opportunities due to improving healthcare infrastructure. As patient preference shifts toward minimally invasive and long-lasting treatment options, the market is likely to witness steady expansion over the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Implantable SNS Devices
  • External SNS Devices

By Application

  • Urinary And Fecal Incontinence
  • Chronic Anal Fissure
  • Urge Incontinence
  • Others

COMPANIES PROFILED

  • Medtronic, Axonics Inc, Boston Scientific Corporation, Nervo Corp, Stimwave Technologies Inc, St Jude Medical, Congentix Medical, Nevro Corp, Laborie Medical Technologies, BlueWind Medical
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SACRAL NERVE STIMULATION MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Implantable SNS Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. External SNS Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SACRAL NERVE STIMULATION MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Urinary And Fecal Incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Chronic Anal Fissure Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Urge Incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SACRAL NERVE STIMULATION MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By Application
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By Application
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By Application
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By Application
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By Application
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL SACRAL NERVE STIMULATION INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic
    • 8.2.2 Axonics Inc
    • 8.2.3 Boston Scientific Corporation
    • 8.2.4 Nervo Corp
    • 8.2.5 Stimwave Technologies Inc
    • 8.2.6 St. Jude Medical
    • 8.2.7 Congentix Medical
    • 8.2.8 Nevro Corp
    • 8.2.9 Laborie Medical Technologies
    • 8.2.10 BlueWind Medical